Company Overview of Dalian Hissen BioPharm Co., Ltd.
Dalian Hissen BioPharm Co., Ltd., a bio-pharmaceutical enterprise, engages in the research and development, production, and sale of vaccine in China. It offers influenza vaccine and recombinant hepatitis B vaccine. The company was founded in 1993 and is based in Dalian, China. It operates a technology development center in Liaoning, China. As of July 9, 2015, Dalian Hissen BioPharm Co., Ltd. operates as a subsidiary of Liaoning Aimei Biological Vaccine Technology Group Co., Ltd.
35 Wanda Road
Economic and Technological Development Zone
Founded in 1993
86 411 87407585
86 411 87549798
Key Executives for Dalian Hissen BioPharm Co., Ltd.
Dalian Hissen BioPharm Co., Ltd. Key Developments
Similar Private Companies By Industry
|Aleph Biological Co., Ltd.||Asia|
|Allist Pharmaceuticals, Inc.||Asia|
|Alpha Pharmaceutical Co.,Ltd. Jiangsu Province||Asia|
|Amerigen Pharmaceuticals Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Dalian Hissen BioPharm Co., Ltd., please visit www.hissen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.